Maria Carmela N Rosales, MD
Nephrology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: 052514 · 052572 · 552559 · 552767 · 552859 · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rosales’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C54935 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · University of Santo Tomas Faculty of Medicine and Surgery.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$82,063
Medicare paid this office $82,063 for 145 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $33,138 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $12,195 | $107 |
| Return visit (30+ min) | 26 | $4,112 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,839 | $71 |
| Hemodialysis procedure with physician evaluation | 27 | $3,184 | $64 |
See all 6 services
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $33,138 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $12,195 | $107 |
| Return visit (30+ min) | 26 | $4,112 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,839 | $71 |
| Hemodialysis procedure with physician evaluation | 27 | $3,184 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,936 | $113 |
Who their Medicare patients are
145 Original Medicare patients in 2024. Average age 68 · Under 65 32% · 85 and older 9% · Women 36% · Also on Medicaid 86% · Health risk score 7.04. Sicker patients than 9 in 10 peers; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 75% · Coronary heart disease 58% · Heart failure 55% · Atrial fibrillation 32% · Depression 32% · Dementia 24% · Stroke 24% · COPD 17% · Cancer 9%.
The office billed $807,448, Medicare allowed $104,803 and paid $82,063; for 605 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 145 | 605 | 68 | 7.04 | $807,448 | $82,063 |
| 2023 | 153 | 632 | 69 | 6.94 | $829,149 | $84,284 |
| 2022 | 173 | 617 | 68 | 6.44 | $800,506 | $81,553 |
| 2021 | 157 | 518 | 68 | 6.31 | $741,703 | $75,667 |
| 2020 | 216 | 873 | 67 | 6.93 | $824,859 | $97,249 |
| 2019 | 199 | 754 | 66 | 6.73 | $581,692 | $84,591 |
| 2018 | 144 | 472 | 65 | 6.11 | $368,600 | $53,519 |
| 2017 | 289 | 1,468 | 73 | 4.72 | $348,641 | $137,644 |
| 2016 | 291 | 1,519 | 73 | 4.79 | $381,853 | $112,330 |
| 2015 | 268 | 1,347 | 73 | 4.43 | $357,358 | $92,288 |
| 2014 | 64 | 208 | 76 | 3.91 | $56,997 | $15,230 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $28,933 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $15,577 | $109 |
| Hemodialysis procedure with physician evaluation | 52 | $6,340 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,678 | $160 |
| Return visit (30+ min) | 26 | $3,568 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,335 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,674 | $120 |
2022: 9 services
| Dialysis services, 1 physician visit per month (20 years or older) | 43 | $35,884 | $189 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $11,221 | $281 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $9,239 | $94 |
| Return visit (30+ min) | 29 | $4,451 | $89 |
| Hemodialysis procedure with physician evaluation | 38 | $3,692 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,633 | $182 |
| Short return visit (20+ min) | 29 | $1,987 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,622 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $993 | $66 |
2021: 8 services
| Dialysis services, 1 physician visit per month (20 years or older) | 48 | $31,758 | $192 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 23 | $17,740 | $265 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,439 | $95 |
| Short return visit (20+ min) | 31 | $2,684 | $44 |
| Hemodialysis procedure with physician evaluation | 20 | $2,564 | $67 |
| Return visit (30+ min) | 15 | $2,403 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,659 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,378 | $125 |
2020: 12 services
| Dialysis services, 1 physician visit per month (20 years or older) | 43 | $35,789 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $15,464 | $97 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $12,388 | $229 |
| Hemodialysis procedure with physician evaluation | 61 | $7,089 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,284 | $189 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $5,228 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,841 | $67 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 11 | $3,537 | $272 |
| Return visit (30+ min) | 29 | $2,365 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,868 | $41 |
| Short return visit (20+ min) | 22 | $1,051 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $667 | $48 |
2019: 9 services
| Dialysis services, 1 physician visit per month (20 years or older) | 52 | $29,673 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $9,183 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 22 | $8,461 | $217 |
| Return visit (30+ min) | 38 | $6,074 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,065 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,470 | $66 |
| Hemodialysis procedure with physician evaluation | 37 | $3,854 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,211 | $115 |
| New patient visit (45+ min) | 20 | $1,858 | $93 |
2018: 9 services
| Dialysis services, 1 physician visit per month (20 years or older) | 30 | $16,330 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $7,677 | $94 |
| Hemodialysis procedure with physician evaluation | 39 | $4,026 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,638 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,334 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,811 | $122 |
| Return visit (30+ min) | 17 | $2,258 | $66 |
| New patient visit (45+ min) | 11 | $1,144 | $104 |
| Short return visit (20+ min) | 14 | $139 | $10 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 114 | $50,183 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $28,656 | $235 |
| Short return visit (20+ min) | 142 | $25,480 | $75 |
| Hemodialysis procedure with physician evaluation | 65 | $15,005 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $6,712 | $181 |
| Long return visit (40+ min) | 11 | $1,603 | $146 |
| Administration of influenza virus vaccine | 13 | $420 | $32 |
| Influenza virus vaccine, not otherwise specified | 13 | $290 | $22 |
| Blood glucose (sugar) test performed by hand-held instrument | 21 | $170 | $3 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 126 | $36,163 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $27,640 | $175 |
| Short return visit (20+ min) | 135 | $16,951 | $57 |
| Hemodialysis procedure with physician evaluation | 74 | $14,510 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $4,452 | $135 |
| New patient visit (45+ min) | 20 | $2,316 | $116 |
| Return visit (30+ min) | 11 | $1,085 | $99 |
| Blood glucose (sugar) test performed by hand-held instrument | 23 | $150 | $3 |
2015: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 104 | $32,138 | $65 |
| Short return visit (20+ min) | 136 | $16,651 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $11,954 | $121 |
| Hemodialysis procedure with physician evaluation | 62 | $10,828 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $6,712 | $181 |
| New patient visit (45+ min) | 33 | $4,445 | $135 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,769 | $138 |
| Administration of influenza virus vaccine | 13 | $413 | $32 |
| Blood glucose (sugar) test performed by hand-held instrument | 48 | $279 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 12 | $153 | $13 |
| Urinalysis, manual test | 20 | $68 | $3 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $5,124 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,921 | $122 |
| Hemodialysis procedure with physician evaluation | 14 | $2,581 | $65 |
| Short return visit (20+ min) | 26 | $1,975 | $68 |
Medicaid work
$12,909 in 2024
Medicaid paid $12,909 for 590 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 282 | $9,401 |
| Return visit (30+ min) | 118 | $2,164 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 112 | $842 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 52 | $400 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $102 |
| 2024 | 590 | 5 | 34 | $12,909 |
| 2023 | 894 | 5 | 38 | $17,997 |
| 2022 | 956 | 10 | 50 | $25,584 |
| 2021 | 992 | 13 | 61 | $25,091 |
| 2020 | 879 | 10 | 46 | $20,904 |
| 2019 | 961 | 10 | 45 | $23,558 |
| 2018 | 625 | 9 | 34 | $13,985 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 356 | $10,872 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 233 | $3,375 |
| Return visit (30+ min) | 203 | $2,583 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 88 | $1,146 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $20 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 445 | $19,785 |
| Return visit (30+ min) | 198 | $1,920 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 96 | $1,728 |
| Short return visit (20+ min) | 75 | $729 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 16 | $659 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 74 | $611 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $98 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 13 | $22 |
| Measurement of magnesium | 12 | $19 |
| Uric acid; blood | 13 | $13 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 440 | $17,829 |
| Short return visit (20+ min) | 208 | $3,474 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 66 | $2,325 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 33 | $502 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 45 | $207 |
| Renal function panel This panel must include the following: Albumin (82040) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphorus inorganic (phosphate) (84100) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 29 | $191 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 31 | $189 |
| Measurement of magnesium | 17 | $129 |
| Creatinine; other source | 15 | $85 |
| Transferase; alanine amino (ALT) (SGPT) | 49 | $48 |
| Uric acid; blood | 29 | $41 |
| Cholesterol level | 15 | $36 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 449 | $11,867 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 114 | $1,882 |
| Return visit (30+ min) | 79 | $1,850 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 28 | $1,470 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 45 | $1,287 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 76 | $1,168 |
| Short return visit (20+ min) | 42 | $487 |
| Service | 13 | $443 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $305 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 21 | $145 |
2019
| Return visit (30+ min) | 270 | $7,653 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 275 | $7,642 |
| Service | 100 | $3,376 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 140 | $2,076 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 26 | $1,098 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 60 | $796 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 23 | $485 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $206 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $159 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $68 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 189 | $6,908 |
| Return visit (30+ min) | 103 | $2,695 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 104 | $1,392 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 87 | $1,144 |
| Service | 17 | $580 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 12 | $475 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $455 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 74 | $238 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $97 |
Drugs they prescribed that Part D paid
$201,562
Pharmacies billed $201,562 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,131) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
945 generic and 186 brand-name prescriptions · $201,562 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 21 | $58,020 | $2,763 |
| Veltassa | 45 | $36,604 | $813 |
| Lokelma | 43 | $30,425 | $708 |
| Sevelamer Carbonate | 56 | $17,022 | $304 |
| Calcium Acetate | 52 | $5,702 | $110 |
See all 24 drugs
| Velphoro | 21 | $58,020 | $2,763 |
| Veltassa | 45 | $36,604 | $813 |
| Lokelma | 43 | $30,425 | $708 |
| Sevelamer Carbonate | 56 | $17,022 | $304 |
| Calcium Acetate | 52 | $5,702 | $110 |
| Sps | 30 | $3,780 | $126 |
| Nifedipine Er | 41 | $1,189 | $29 |
| Bumetanide | 12 | $1,135 | $95 |
| Furosemide | 161 | $1,009 | $6 |
| Cinacalcet | 18 | $975 | $54 |
| Hydralazine | 29 | $505 | $17 |
| Valsartan | 16 | $409 | $26 |
| Carvedilol | 89 | $297 | $3 |
| Losartan | 79 | $276 | $3 |
| Gentamicin Sulfate | 13 | $254 | $20 |
| Metoprolol | 21 | $218 | $10 |
| Atorvastatin | 42 | $192 | $5 |
| Amlodipine Besylate | 93 | $184 | $2 |
| Prednisone | 12 | $123 | $10 |
| Metoprolol | 16 | $122 | $8 |
| Potassium Chloride | 11 | $120 | $11 |
| Gabapentin | 28 | $120 | $4 |
| Pantoprazole | 17 | $68 | $4 |
| Lisinopril | 14 | $54 | $4 |
Year by year
| 2024 | 1,131 | 106 | 0% (0) | 16% | $201,562 |
| 2023 | 932 | 117 | 0% (0) | None | $234,038 |
| 2022 | 1,078 | 145 | 0% (0) | 17% | $196,424 |
| 2021 | 1,274 | 133 | 0% (0) | 16% | $144,534 |
| 2020 | 1,084 | 137 | 0% (0) | None | $127,693 |
| 2019 | 911 | 165 | 0% (0) | 23% | $180,936 |
| 2018 | 1,611 | 296 | None | 19% | $300,066 |
| 2017 | 2,898 | 349 | 2% (49) | 21% | $634,188 |
| 2016 | 2,532 | 331 | 4% (88) | 22% | $508,059 |
| 2015 | 1,249 | 201 | 3% (39) | 26% | $232,863 |
| 2014 | 104 | 49 | None | 26% | $23,914 |
| 2013 | 36 | 15 | 0% (0) | None | $3,078 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Renvela | 16 | $52,175 | $3,261 |
| Velphoro | 12 | $30,410 | $2,534 |
| Lokelma | 28 | $26,052 | $930 |
| Sevelamer Carbonate | 32 | $22,422 | $701 |
| Cinacalcet | 18 | $22,398 | $1,244 |
| Calcium Acetate | 44 | $7,538 | $171 |
| Sps | 50 | $7,263 | $145 |
| Prosol | 24 | $5,455 | $227 |
| Bumetanide | 13 | $3,811 | $293 |
| Furosemide | 132 | $2,223 | $17 |
| Nifedipine Er | 17 | $1,616 | $95 |
| Valsartan | 11 | $1,484 | $135 |
| Losartan | 58 | $1,104 | $19 |
| Carvedilol | 59 | $1,061 | $18 |
| Amlodipine Besylate | 100 | $948 | $9 |
| Gabapentin | 21 | $577 | $27 |
| Atorvastatin | 11 | $552 | $50 |
| Gentamicin Sulfate | 16 | $510 | $32 |
| Metoprolol | 18 | $371 | $21 |
| Hydralazine | 21 | $333 | $16 |
| Calcitriol | 11 | $315 | $29 |
| Tamsulosin | 11 | $289 | $26 |
| Potassium Chloride | 13 | $278 | $21 |
| Metoprolol | 18 | $275 | $15 |
| Allopurinol | 12 | $263 | $22 |
| Lactulose | 15 | $165 | $11 |
| Fosinopril | 13 | $102 | $8 |
2022: 25 drugs
| Sevelamer Carbonate | 42 | $48,060 | $1,144 |
| Lokelma | 32 | $25,777 | $806 |
| Retacrit | 22 | $13,359 | $607 |
| Cinacalcet | 17 | $11,573 | $681 |
| Calcium Acetate | 61 | $10,734 | $176 |
| Sps | 35 | $4,124 | $118 |
| Furosemide | 162 | $1,359 | $8 |
| Amlodipine Besylate | 134 | $1,119 | $8 |
| Hydralazine | 35 | $725 | $21 |
| Losartan | 61 | $721 | $12 |
| Carvedilol | 63 | $692 | $11 |
| Metoprolol | 24 | $542 | $23 |
| Calcitriol | 15 | $517 | $34 |
| Atorvastatin | 20 | $481 | $24 |
| Isosorbide Mononitrate Er | 11 | $419 | $38 |
| Gabapentin | 15 | $309 | $21 |
| Omeprazole | 14 | $254 | $18 |
| Lisinopril | 24 | $198 | $8 |
| Tamsulosin | 16 | $186 | $12 |
| Metoprolol | 19 | $171 | $9 |
| Nifedipine Er | 11 | $164 | $15 |
| Hydrochlorothiazide | 15 | $130 | $9 |
| Clonidine | 15 | $123 | $8 |
| Gemfibrozil | 12 | $54 | $4 |
| Insulin | 16 | $23 | $1 |
2021: 27 drugs
| Sevelamer Carbonate | 50 | $19,420 | $388 |
| Lokelma | 20 | $14,836 | $742 |
| Calcium Acetate | 78 | $10,772 | $138 |
| Retacrit | 23 | $9,460 | $411 |
| Cinacalcet | 23 | $7,136 | $310 |
| Clinisol | 33 | $5,666 | $172 |
| Sodium Polystyrene Sulfonate | 17 | $1,608 | $95 |
| Sps | 24 | $1,440 | $60 |
| Furosemide | 158 | $1,213 | $8 |
| Carvedilol | 101 | $1,162 | $12 |
| Amlodipine Besylate | 161 | $1,038 | $6 |
| Hydralazine | 40 | $787 | $20 |
| Nifedipine Er | 12 | $591 | $49 |
| Losartan | 73 | $536 | $7 |
| Atorvastatin | 27 | $510 | $19 |
| Isosorbide Mononitrate Er | 18 | $486 | $27 |
| Metoprolol | 15 | $369 | $25 |
| Omeprazole | 28 | $296 | $11 |
| Metolazone | 12 | $281 | $23 |
| Gabapentin | 20 | $187 | $9 |
| Lisinopril | 35 | $156 | $4 |
| Prednisone | 18 | $145 | $8 |
| Metoprolol | 15 | $138 | $9 |
| Famotidine | 15 | $106 | $7 |
| Hydrochlorothiazide | 19 | $59 | $3 |
| Tamsulosin | 14 | $53 | $4 |
| Insulin | 17 | $26 | $2 |
2020: 24 drugs
| Sevelamer Carbonate | 34 | $15,161 | $446 |
| Calcium Acetate | 80 | $11,345 | $142 |
| Retacrit | 19 | $9,553 | $503 |
| Lidocaine | 12 | $5,263 | $439 |
| Sodium Polystyrene Sulfonate | 29 | $3,137 | $108 |
| Clonidine | 12 | $1,445 | $120 |
| Potassium Chloride | 16 | $1,315 | $82 |
| Sps | 21 | $1,258 | $60 |
| Furosemide | 159 | $1,129 | $7 |
| Hydralazine | 27 | $658 | $24 |
| Carvedilol | 79 | $644 | $8 |
| Amlodipine Besylate | 150 | $644 | $4 |
| Calcitriol | 24 | $581 | $24 |
| Doxazosin Mesylate | 16 | $388 | $24 |
| Losartan | 32 | $240 | $8 |
| Metolazone | 13 | $221 | $17 |
| Atorvastatin | 25 | $219 | $9 |
| Fosinopril | 13 | $217 | $17 |
| Omeprazole | 13 | $199 | $15 |
| Gabapentin | 19 | $147 | $8 |
| Metoprolol | 20 | $133 | $7 |
| Lisinopril | 27 | $130 | $5 |
| Benazepril | 13 | $86 | $7 |
| Tamsulosin | 15 | $48 | $3 |
2019: 24 drugs
| Renvela | 17 | $76,514 | $4,501 |
| Sevelamer Carbonate | 18 | $22,410 | $1,245 |
| Veltassa | 11 | $10,946 | $995 |
| Calcium Acetate | 62 | $7,546 | $122 |
| Novolog Flexpen | 11 | $6,460 | $587 |
| Clonidine | 12 | $2,793 | $233 |
| Furosemide | 136 | $1,199 | $9 |
| Potassium Chloride | 13 | $1,044 | $80 |
| Sodium Polystyrene Sulfonate | 13 | $923 | $71 |
| Hydralazine | 25 | $665 | $27 |
| Amlodipine Besylate | 85 | $517 | $6 |
| Losartan | 46 | $421 | $9 |
| Calcitriol | 18 | $420 | $23 |
| Carvedilol | 48 | $408 | $8 |
| Doxazosin Mesylate | 14 | $322 | $23 |
| Allopurinol | 12 | $244 | $20 |
| Gabapentin | 30 | $243 | $8 |
| Fosinopril | 11 | $234 | $21 |
| Atorvastatin | 20 | $232 | $12 |
| Lisinopril | 24 | $232 | $10 |
| Metoprolol | 32 | $230 | $7 |
| Metolazone | 12 | $194 | $16 |
| Famotidine | 17 | $133 | $8 |
| Benazepril | 19 | $128 | $7 |
2018: 40 drugs
| Renvela | 40 | $109,342 | $2,734 |
| Veltassa | 23 | $27,800 | $1,209 |
| Procrit | 13 | $25,242 | $1,942 |
| Sevelamer Carbonate | 20 | $18,354 | $918 |
| Januvia | 15 | $10,296 | $686 |
| Calcium Acetate | 48 | $6,578 | $137 |
| Dexilant | 20 | $6,544 | $327 |
| Novolog Flexpen | 12 | $6,522 | $544 |
| Raloxifene | 15 | $3,856 | $257 |
| Metoprolol | 26 | $1,348 | $52 |
| Losartan | 117 | $1,038 | $9 |
| Proair Hfa | 15 | $926 | $62 |
| Omeprazole | 38 | $916 | $24 |
| Levothyroxine | 36 | $916 | $25 |
| Amlodipine Besylate | 114 | $915 | $8 |
| Atorvastatin | 40 | $861 | $22 |
| Allopurinol | 39 | $853 | $22 |
| Simvastatin | 57 | $834 | $15 |
| Calcitriol | 32 | $654 | $20 |
| Tamsulosin | 24 | $627 | $26 |
| Furosemide | 96 | $590 | $6 |
| Hydralazine | 32 | $570 | $18 |
| Doxazosin Mesylate | 21 | $493 | $23 |
| Sodium Polystyrene Sulfonate | 18 | $388 | $22 |
| Atenolol | 11 | $376 | $34 |
| Metoprolol | 69 | $375 | $5 |
| Montelukast | 13 | $323 | $25 |
| Lisinopril | 47 | $321 | $7 |
| Benazepril | 26 | $317 | $12 |
| Pravastatin | 13 | $282 | $22 |
| Carvedilol | 40 | $265 | $7 |
| Clonidine | 29 | $253 | $9 |
| Isosorbide Mononitrate Er | 16 | $230 | $14 |
| Fluticasone Propionate | 15 | $146 | $10 |
| Alendronate | 13 | $144 | $11 |
| Glipizide | 12 | $141 | $12 |
| Metformin | 15 | $134 | $9 |
| Gabapentin | 21 | $107 | $5 |
| Hydrochlorothiazide | 13 | $76 | $6 |
| Famotidine | 13 | $62 | $5 |
2017: 57 drugs
| Renvela | 100 | $239,958 | $2,400 |
| Sensipar | 60 | $114,055 | $1,901 |
| Creon | 13 | $41,570 | $3,198 |
| Procrit | 31 | $38,766 | $1,251 |
| Januvia | 48 | $25,740 | $536 |
| Veltassa | 20 | $18,950 | $948 |
| Dexilant | 28 | $8,782 | $314 |
| Calcium Acetate | 55 | $6,938 | $126 |
| Lantus Solostar | 19 | $4,445 | $234 |
| Proair Hfa | 33 | $2,626 | $80 |
| Midodrine | 18 | $2,533 | $141 |
| Metoprolol | 30 | $1,799 | $60 |
| Raloxifene | 11 | $1,513 | $138 |
| Allopurinol | 78 | $1,452 | $19 |
| Doxazosin Mesylate | 50 | $1,327 | $27 |
| Atorvastatin | 97 | $1,301 | $13 |
| Calcitriol | 41 | $1,256 | $31 |
| Losartan | 180 | $1,239 | $7 |
| Nifedipine Er | 18 | $1,238 | $69 |
| Levothyroxine | 41 | $1,168 | $28 |
| Omeprazole | 83 | $1,012 | $12 |
| Hydralazine | 45 | $969 | $22 |
| Amlodipine Besylate | 133 | $831 | $6 |
| Simvastatin | 96 | $733 | $8 |
| Tamsulosin | 30 | $712 | $24 |
| Furosemide | 122 | $711 | $6 |
| Pravastatin | 22 | $620 | $28 |
| Metoprolol | 109 | $620 | $6 |
| Metformin | 53 | $384 | $7 |
| Lisinopril | 52 | $360 | $7 |
| Fluticasone Propionate | 28 | $335 | $12 |
| Montelukast | 20 | $328 | $16 |
| Minoxidil | 18 | $323 | $18 |
| Benazepril | 37 | $312 | $8 |
| Gabapentin | 45 | $295 | $7 |
| Clonidine | 32 | $288 | $9 |
| Glipizide | 46 | $279 | $6 |
| Clopidogrel | 21 | $275 | $13 |
| Atenolol | 24 | $267 | $11 |
| Pioglitazone | 14 | $265 | $19 |
| Alendronate | 28 | $262 | $9 |
| Hydroxyzine | 14 | $257 | $18 |
| Carvedilol | 33 | $248 | $8 |
| Hydrocodone-Acetaminophen | 13 | $241 | $19 |
| Warfarin | 22 | $229 | $10 |
| Losartan-Hydrochlorothiazide | 18 | $184 | $10 |
| Triamcinolone Acetonide | 14 | $184 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $143 | $13 |
| Isosorbide Mononitrate Er | 16 | $139 | $9 |
| Pantoprazole | 11 | $135 | $12 |
| Cephalexin | 24 | $116 | $5 |
| Sertraline | 12 | $116 | $10 |
| Hydrochlorothiazide | 24 | $111 | $5 |
| Azithromycin | 18 | $111 | $6 |
| Acetaminophen-Codeine | 12 | $102 | $9 |
| Zolpidem | 20 | $101 | $5 |
| Tramadol | 18 | $71 | $4 |
2016: 61 drugs
| Renvela | 111 | $252,482 | $2,275 |
| Sensipar | 60 | $101,709 | $1,695 |
| Januvia | 38 | $20,977 | $552 |
| Calcium Acetate | 46 | $8,480 | $184 |
| Advair Diskus | 16 | $5,469 | $342 |
| Aripiprazole | 12 | $4,269 | $356 |
| Phenobarbital | 15 | $2,818 | $188 |
| Dexilant | 11 | $2,670 | $243 |
| Doxazosin Mesylate | 69 | $1,944 | $28 |
| Allopurinol | 62 | $1,318 | $21 |
| Calcitriol | 44 | $1,261 | $29 |
| Levothyroxine | 38 | $1,228 | $32 |
| Lidocaine-Prilocaine | 31 | $1,069 | $34 |
| Nifedipine Er | 13 | $1,037 | $80 |
| Hydralazine | 58 | $1,014 | $17 |
| Metoprolol | 25 | $972 | $39 |
| Atorvastatin | 70 | $817 | $12 |
| Hydrocodone-Acetaminophen | 34 | $803 | $24 |
| Losartan | 100 | $778 | $8 |
| Amlodipine Besylate | 126 | $758 | $6 |
| Proair Hfa | 12 | $749 | $62 |
| Lansoprazole | 12 | $708 | $59 |
| Simvastatin | 75 | $699 | $9 |
| Omeprazole | 66 | $688 | $10 |
| Novofine 32 | 16 | $639 | $40 |
| Potassium Chloride | 16 | $638 | $40 |
| Klor-Con 8 | 11 | $622 | $57 |
| Metoprolol | 69 | $548 | $8 |
| Diphenoxylate-Atropine | 15 | $519 | $35 |
| Fluticasone Propionate | 40 | $437 | $11 |
| Furosemide | 96 | $429 | $4 |
| Metformin | 41 | $404 | $10 |
| Carvedilol | 48 | $338 | $7 |
| Triamcinolone Acetonide | 20 | $337 | $17 |
| Acetaminophen-Codeine | 24 | $293 | $12 |
| Atenolol | 29 | $275 | $9 |
| Warfarin | 23 | $275 | $12 |
| Lisinopril | 34 | $260 | $8 |
| Clopidogrel | 13 | $256 | $20 |
| Clonidine | 25 | $247 | $10 |
| Benazepril | 25 | $239 | $10 |
| Gabapentin | 42 | $221 | $5 |
| Pantoprazole | 12 | $213 | $18 |
| Mycophenolate Mofetil | 12 | $206 | $17 |
| Glipizide | 38 | $197 | $5 |
| Minoxidil | 16 | $175 | $11 |
| Fosinopril | 15 | $168 | $11 |
| Alendronate | 13 | $117 | $9 |
| Isosorbide Mononitrate Er | 12 | $108 | $9 |
| Lorazepam | 17 | $106 | $6 |
| Isoniazid | 18 | $102 | $6 |
| Azithromycin | 15 | $93 | $6 |
| Hydroxyzine | 11 | $90 | $8 |
| Tramadol | 20 | $87 | $4 |
| Hydrochlorothiazide | 15 | $75 | $5 |
| Zolpidem | 15 | $75 | $5 |
| Ciprofloxacin | 11 | $69 | $6 |
| Diazepam | 11 | $66 | $6 |
| Cephalexin | 18 | $64 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $55 | $5 |
| Alprazolam | 11 | $52 | $5 |
2015: 36 drugs
| Renvela | 66 | $137,465 | $2,083 |
| Sensipar | 17 | $25,889 | $1,523 |
| Nexium | 11 | $5,301 | $482 |
| Januvia | 12 | $5,095 | $425 |
| Advair Diskus | 11 | $3,537 | $322 |
| Calcium Acetate | 18 | $2,667 | $148 |
| Raloxifene | 13 | $1,457 | $112 |
| Calcitriol | 39 | $834 | $21 |
| Doxazosin Mesylate | 34 | $774 | $23 |
| Levothyroxine | 28 | $580 | $21 |
| Metoprolol | 12 | $499 | $42 |
| Losartan | 58 | $432 | $7 |
| Hydralazine | 25 | $417 | $17 |
| Allopurinol | 16 | $375 | $23 |
| Hydrocodone-Acetaminophen | 16 | $350 | $22 |
| Atorvastatin | 16 | $317 | $20 |
| Carvedilol | 30 | $301 | $10 |
| Omeprazole | 32 | $294 | $9 |
| Warfarin | 14 | $275 | $20 |
| Glimepiride | 13 | $275 | $21 |
| Zolpidem | 27 | $247 | $9 |
| Furosemide | 55 | $247 | $4 |
| Amlodipine Besylate | 45 | $222 | $5 |
| Simvastatin | 35 | $214 | $6 |
| Fluticasone Propionate | 20 | $206 | $10 |
| Ciprofloxacin | 14 | $194 | $14 |
| Gabapentin | 26 | $182 | $7 |
| Metoprolol | 35 | $176 | $5 |
| Amiodarone | 14 | $157 | $11 |
| Lisinopril | 16 | $123 | $8 |
| Benazepril | 18 | $121 | $7 |
| Azithromycin | 18 | $107 | $6 |
| Acetaminophen-Codeine | 12 | $104 | $9 |
| Alprazolam | 11 | $97 | $9 |
| Famotidine | 11 | $75 | $7 |
| Diazepam | 11 | $57 | $5 |
2013: 1 drug
| Amlodipine Besylate | 11 | $110 | $10 |
Money from drug and device companies
$14 in 2023
A payment is not proof that care is biased.
| Calliditas Therapeutics US | Tarpeyo | $14 | 1 payment
|
See the published payment
| Calliditas Therapeutics US | Education · 2023-11-15 | Tarpeyo | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780706762
- Licence
- CA 54935California C54935: Current · expires 2027-04-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2360 Mckee Rd, Suite 10, San Jose, CA, 95116
- NPI first listed
- 2007-04-03
- NPI last updated
- 2014-07-24
This is when the NPI record was last certified, not a medical board exam.